Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Jennison Associates LLC reported a 5.50% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
Jennison Associates LLC reported a 5.50% stake in Arcutis Biotherapeutics, Inc., 6,758,006 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 6,758,006
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Jennison Associates LLC | 5.50% | 6,758,006 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Jennison Associates LLC
- Arcutis Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Jennison Associates LLC · May 6, 2026
- Schedule 13G/A · Jennison Associates LLC · Oct 6, 2025
- Schedule 13G/A · Jennison Associates LLC · May 8, 2025
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026